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This article analyses the experiences of the association movement in
Latin America that brings together individuals and families with rare
(RD) or low prevalence diseases (LPD). It also looks at their needs from
global health, social, research and education perspectives. The nature
of social work assessments and interventions in rare diseases helps us
better understand the needs of people with RDs or LPDs and facilitates
the creation of associations. Social work aims at consolidating the
social fabric that will lead to the recognition of RDs as a health and
social priority at an international level.
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Experiences of the Low Prevalence Diseases
Association Movement in Latin America
The concept and the definition of ‘rare diseases’ are fundamentally based on criteria of prevalence and severity. Rare
diseases are those in which there is danger of death or chronic
disability, and low incidence (less than 5 cases per 10,000 people in Europe), according to the European Commission (Comisión Europea, 1999) and Posada, Martin-Arribas, Ramirez, Villaverde, and Abaitua (2008). We can find other names, such as
low frequency disease, minor incidence disease, invisible disease, forgotten disease, orphan disease, uncommon disease, or
catastrophic disease. In Latin America, the most frequent name
is low prevalence disease. The patients and the associations that
support them emphasize the importance of realizing that rare
diseases can affect anyone at any stage of life. As the president
of the Association of Relatives and those affected by Lipodystrophies (AELIP), says, “It’s not strange to suffer from a rare disease. The disease is rare, not the people who suffer them” (Pérez
de Tudela, 2013). From the medical perspective, rare diseases
are characterized by a large number and wide diversity of disorders and symptoms that vary not only from one disease to another, but also within the same pathology. The same conditions
can have different clinical manifestations on different persons.
Many disorders have a remarkable number of subtypes. It is
estimated that there are more than 7,000 rare diseases affecting
the patients’ physical, mental and sensory capabilities.
The rare diseases (RD) association movement has gained
considerable strength and recognition in public forums in many
countries (Carrión, Echandi, Banon, & Pastor, 2015). RDs are not
circumscribed to races or countries; they can appear at any stage
of life and anywhere in the world. It is estimated that 42 million
people are affected by RDs in Latin America (ALIBER, 2016).
The Latin American Alliance of Rare Diseases (ALIBER) is a
nonprofit coalition that brings together several organizations of
families and patients of Rare Diseases (RD) or Low Prevalence
Diseases (LPD) that exist in Latin America.
In 2013, the Year of Rare Diseases in Spain, the Association
for Rare Diseases D’Genes and the Spanish Federation of Rare
Diseases (FEDER) created ALIBER, with the aims of sharing
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knowledge and best practices, and improving the situation of
people and families living with a rare disease in Latin America.
D´Genes began this initiative after many requests for information from Latin American countries, which made evident the
need for it. The Information and Orientation Service (SIO) of
FEDER also received an increased number of requests for information and other assistance from Latin American countries
(Arcos, Solves, & Rius, 2016). Since 2002 the SIO responded to
3564 queries, as detailed in figure 1.
Figure 1. Distribution of queries on RD from Latin America received
by SIO-FEDER since 2012.
Country		

No. of visits

Argentina			961
Mexico				571
Colombia			465
Peru				326
Chile				323
Venezuela			196
Ecuador			104
Uruguay			 90
Cuba				 86
Brazil				 66
Guatemala			 64
Bolivia				 45
Portugal			 45
Costa Rica			
37
Panama				 32
El Salvador			
31
Spain				 29
Honduras			 23
Paraguay			 23
Nicaragua			 21
Dominican Republic		
19
Andorra			
7
TOTAL			

3564

Source: SIO FEDER (http://www.enfermedades-raras.org/)
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It became clear that there was an urgent need to establish
a joint collaboration among Spanish-speaking countries to respond to this demand. The 2012 agreement among the FEDER
foundation, the Colombian Federation of rare diseases (FECOER), and the Spanish Foundation of Help for Guatemala provided a strong precedent. This agreement marked the beginning of
this international collaboration. During 2012 and 2013, FEDER
worked with Latin America to contact other organizations of
patients interested in participating in the project. The end of
2012 witnessed the agreement among the Portuguese Federation of Rare Diseases (FEDRA), the Mexican organization of
Rare Diseases (OMER), and the Colombian Foundation CRONICARE (Carrión et al., 2015, p. 116).
Since then, D´Genes, together with Mrs. Elizabeth Zabalza,
Director of the Spanish Foundation for Help to Guatemala; Mr.
Javier Guerra, Delegate of Mundo Marfan Latino; and Mrs.
Claudia Delgado, Delegate of FEDER, planned the first Latin
American meeting of rare diseases, which was held in October
2013 in Totana, Murcia, Spain. At this event, the Latin American Alliance of Rare Diseases (ALIBER) was created and its
first Board of Directors was elected. Its mission included the
creation of a network of organizations for patients with rare diseases prevalent in Latin America, the coordination of actions to
strengthen the alliance, creating public awareness of RDs, and
representing RD patients in local, regional, national and international agencies. This created a forum of permanent collaboration for sharing knowledge, experiences, and best practices in
the areas of health, education, and work (ALIBER, 2016).
As for its vision, ALIBER seeks to be a coalition that brings
together and empowers the different associations of RD patients
in Latin America that defend the rights of the patients and their
families. It disseminates information about legal rights and inequalities affecting people with rare diseases in different parts
of the world. Towards this end, ALIBER works with other agencies and governments to improve the rights and the quality of
life for those families. For the first time, in 2014, the International
Day of Rare Diseases was held, and a Decalogue for the defense
of the rights of people with rare diseases in Latin America was
created. The Second Latin American Congress on Rare Diseases
was held in Lisbon, Portugal, in 2014; the Third Latin American
Congress on Rare Diseases was held in Guadalajara, Mexico,
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in July 2015; and the Fourth Latin American Congress on Rare
Diseases was held in Montevideo, Uruguay in September 2016
(ALIBER, 2016).
It is worth noting that the first congress established the guidelines for the subsequent ones (Bañón & Fornieles, 2013). The First
Latin American Congress on Rare Diseases was held on October
14-18, 2013, in Totana, Murcia, Spain. It was organized by D’Genes
and the Spanish Federation of Rare Diseases and convened professionals as well as delegates from associations. Participating
entities included the Colombian Federation of Rare Diseases
(FECOER), the Argentinian Federation of Diseases of Low Prevalence (FADEPOF), the All Together Rare Diseases Association
Uruguay (ATUERU), the Mundo Marfan Latino, CRONICARE
Foundation of Colombia, the Ecuadorian Foundation of Patients
with Lysosomal Storage (FEPEL-DASHA), the Mexican Federation of Rare Diseases (FEMEXER), the Argentinian Support
Group for Patients with Rare Diseases (GADAPER), the Mexican
Association of Patients with Lysosomal Storage (ACOPEL), the
Mexican Organization of Rare Diseases (OMER), the Paolist Association of Mucopolysaccharidosis and Rare Diseases (AMPS e
Rarissimas) of Brazil, the Federation of Rare Diseases of Portugal
(FEDRA), the Orientation and Information Service of Guatemala, and the Augusto Turenne Foundation of Uruguay. As can be
seen, this international congress brought together a wide range
of organizations.
Without a doubt, the development of an international movement is crucial to promoting solid and enduring improvements
in diagnosis, treatment, and equitable access to social and psychological educational resources. For this reason, the common
goal is to make this network as wide as possible. The first congress linked the above-mentioned agencies with EURORDIS,
the European rare diseases organization. We must ensure, however, that the conclusions and agreements reached during these
congresses lead to significant action. One of the most important
outcomes of these congresses has been the buy-in of all members of ALIBER and the election of a Board of Directors. Most
significantly, the congress generated a climate of cooperation
that will permeate all future work. It is vital to develop joint
projects between Spain and Latin America, and to disseminate positive work models and best practices to other countries
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(ALIBER, 2016). For this reason, it is also important to share
information about negative experiences and failed initiatives.
ALIBER is currently composed of 26 organizations that represent 497 associations in 14 countries. Spain is the country with
the highest number of associations (Spanish Federation of Rare
Diseases, FEDER: 320 associations), followed by Argentina (Argentinian Federation of Diseases of Low Prevalence, FADEPOF:
62), Mexico (Mexican Organization of Rare Diseases, OMER:
19), Uruguay (All Together Rare Diseases Uruguay, ATUERU:
17), and Portugal (Federation of Rare Diseases of Portugal, FEDRA: 16) (ALIBER, 2016).
The work of ALIBER in partnership with nonprofit organizations of Latin America has increased public awareness of rare
diseases and has turned them into more of a political, health and
social priority by the national health systems of ALIBER-member
countries (ALIBER, 2016). Victims of rare diseases and their relatives are protagonists in the consolidation of this international
movement. This movement and related associations have come
to answer their questions and respond to their needs.

Features and Purpose of Organizations
Related to Rare Diseases
The following are some of the features that characterize the
organizations within the rare diseases association movement in
Latin America: (a) they were founded by patients or their relatives; (b) they have arisen from the need to create a meeting
point and common work arena; (c) they enable patients to contact each other and meet specialists in their particular health
area; (d) they offer patients access to treatments and information about their pathology and rights; and (e) they aim to influence public policies and generate changes in the public health
systems that may improve the quality of life for affected people.
Patient organizations play a key role in the new biopsychosocial model of health. These patient organizations are being
recognized for their knowledge of patients’ needs, their ability
to collaborate, and their experience in putting RDs on the agenda of every country’s health systems (Borrell-Carrió, Suchman,
& Epstein, 2004). The primary purpose of RD organizations is
to collaborate with health professionals in the care of patients.
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The strategic objectives of ALIBER are: to increase public
awareness of rare diseases as social, educational, work and
health priorities; to represent people with rare diseases in Latin
America; and to empower its member agencies.
In view of the above objectives and in response to its organizational mission and vision, ALIBER seeks to:
•

Increase social visibility through:
—Strengthening its strategic communication
through its web page and other social media
—Sensitizing key players in RD such as professionals,
students, patients and governments
—Bringing together key players in this movement
through international congresses on Rare Diseases.

•

Defend Human Rights through:
—Establishing working relations and negotiations
with the pharmaceutical industry for access to
orphan drugs
—Promoting the creation of alliances with
organizations related to health and disability in
Latin America
—Increasing political influence and social
mobilization in an effort to incorporate RD
in health plans in Latin America
—Promoting international cooperation
—Creating a document identifying each country’s
policy in terms of RD health, education, work
and research

•

Provide Training and Disseminate Knowledge through:
—Training a critical mass of professionals, doctors
and researchers through the Latin American
RD School
—Promoting a model of care in RDs in each
country through consensus
—Establishing Alliances and Solidarity Networks
to stimulate the multilateral cooperation of all
sectors and actors related to RD in Latin America
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•

Effectively Manage Associations through:
—Knowing and managing the challenges of the
associations’ movement in every country.
This includes identifying the needs and problems
related to RDs and their demands in terms of
social participation
—Promoting the creation of RD organizations and
associations in Latin America
—Promoting the participation of associations in
international RD congresses.

•

Engage in Social Action through:
—The empowerment of associations and the
development of RD Information and Orientation
Services (SIO). SIO identifies the needs of affected
people and thus develops a social action through
improvement proposals based on knowledge
of RD reality (ALIBER, 2016).

Challenges to Safeguarding
Equality of Health Rights
According to Palau (2010), and Saltonstall and Scott (2013),
the main health problems of people suffering from RDs include
misdiagnosis, lack of information, lack of scientific knowledge,
lack of the appropriate quality care, high cost of the few existing
drugs and treatment, and inequality of access to treatment and
care, all of which will be explored below.
Misdiagnosis
Delays between the onset of the first symptoms and proper
diagnosis involve high risks to patients’ health. Misdiagnoses
often lead to inadequate treatment in what could be described
as the pre-diagnostic labyrinth. The average time between the
onset of the first symptoms and diagnosis is 5 years, and for
20% of the sufferers, it can be 10 years or more (FEDER, 2009,
pp. 43-44). Many more patients are still waiting for a diagnosis. FEDER (2009) received more than 3,160 queries from people without diagnosis seeking help. According to the ENSERIO
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study (Study of Health and Social needs of people with a RD
and their families), more than 40% of people with a diagnostic
delay receive inadequate treatment or no support whatsoever
(FEDER, 2009, p. 47).
Consequences of the delay can be detrimental to patients
and their families. This delay deprives patients of the needed
therapeutic intervention and often results in physical, intellectual and psychological deterioration. All of these could have
been avoided with a more rapid diagnosis. Moreover, a late diagnosis leads to greater difficulty in accessing social help (Avellaneda et al., 2007).
Lack of information, scientific
knowledge, and appropriate quality care
Useful and timely information is needed about the diseases
and about places where proper help can be obtained. It is important to highlight that the lack of qualified professionals in
the RD area represents a serious problem (Esteban, Ruano,
Guerra, & Motero, 2015). Lack of scientific knowledge makes
it difficult to develop therapeutic tools, defining intervention
strategies and identifying appropriate medicines and medical
approaches. Without combining the different knowledge fields
associated to RDs, such as physiotherapy, nutrition, psychology,
social work, etc., people affected can live for years in unstable
conditions, without competent medical attention or rehabilitation. They often remain excluded from the health care system,
even after diagnosis.
High cost of the few existing drugs and treatment
and inequality of access to treatment and care
The high cost of health care and drugs, combined with the
lack of social benefits, causes an impoverishment of the family
and drastically increases inequality of access to care for RD patients (Graf & Frank, 2015). There is unequal access to innovative
treatments due to delays in price setting and refund decisions.
Additionally, doctors lack experience, and few are involved in
RD clinical trials. There is also lack of consensus about best
treatments.

Journal of Sociology & Social Welfare

178

Human Rights Related to Education
and Communication: Problems
Integrating School, Work and Society
Rare or low prevalence diseases have significant adverse impacts on the physical health of the sufferers to the point of endangering their lives. This danger in combination with social and
relevant psychological processes negatively impacts the well-being of the patients. RDs may lead to stigmatization, exclusion,
low self-esteem, loneliness, and discrimination in affective relations, employment, finances, and/or the way they are represented
in the media. In fact, when asked, patients often make reference
to their social, educational and communication needs (FEDER,
2009; Jaeger, Rojvik, & Berglund, 2015; Pavol, 2015).
RDs have implications for all areas of life including education, job choice, leisure activities, and relationships with friends
or one’s partner. They can lead to stigmatization, isolation, exclusion from the community, difficulty in obtaining insurance
(travel, life, mortgage, etc.), and reduction of job opportunities.
RDs affect education in particular. Fornieles et al. (2014),
comment on the following 14 major topics that are relevant to
RDs in Latin America:
•

It is necessary to create interdisciplinary groups
that consider rare diseases, gather experiences and
offer solutions. All key players must be present
in the group [pupils, teachers (also with rare
diseases), parents (also with rare diseases), etc.].

•

The lack of understanding of low prevalence diseases
is common in schools. This ignorance spawns
prejudices related to what students with these
conditions can or cannot achieve.

•

It is necessary to identify educational models that
will effectively mainstream children with RDs.
These models should lead to innovative projects
and curricular adaptations.
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•

RDs must become part of primary and secondary
education curricula. Because of their interdisciplinary
nature, they can be incorporated into subjects as
diverse as science, art, humanities, or new technologies.

•

We must continue the efforts to share information
and increase sensitization regarding RDs. This
sensitization should focus on the search for equality
and social justice in education, health and employment.

•

Students with RDs represent a special challenge to
their families. Educational institutions should make
every effort to support families, and particularly
siblings attending the same school. Families must
be encouraged not to avoid the problem and not to
overprotect these children.

•

Students with RDs may become our future doctors, 		
teachers, journalists or managers. Their education
is important for our society in general, even though
it represents a challenge. Challenges help people grow.

•

We must pay special attention to the transitions
between the different stages of education. Ignorance
of RDs may result in the need to repeat educational
content at the beginning of every semester or
academic year, and may lead to the loss of
educational support. It is particularly necessary
to support students with RDs as they transition
from secondary education to college and from
college to higher university degree programs.

•

Research on education and RDs must increase. It is
important for researchers to contact persons with
RDs who have been university students in order to
identify the hurdles they encountered. Researchers
are encouraged to visit educational institutions to
interview students and teachers.

•

Self-image during childhood and adolescence has
not been taken sufficiently into account. This is
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significant, given that victims of physically visible
and invisible RDs may experience discrimination
and bullying that may damage their self-image.
•

On occasion, students with RDs are excluded from
extracurricular activities, assuming that they cannot
or do not want to participate. This may be due to
teachers’ reluctance. We should examine whether
this problem can be solved with professional help
or with the use of a mediator.

•

There is a need to improve the collaboration
between schools and hospitals, given that some
pathologies require frequent hospitalizations for
treatment or due to complications.

•

RDs have become a new field in biomedical
research. The same level of interest is necessary
as we look at education. There is a need for original
alternatives that may facilitate on-campus and
off-campus education.

•

Experts in teaching and pedagogy must collaborate
with the Institutes of Education Sciences and
Teachers Centers to generate proposals for new
methodologies.

Problems in communication
During the last 3 years, the FEDER agency has conducted
an exhaustive analysis of RDs in Spain (Solves, Bañón, & Rius,
2015). Without a doubt, the same should be done in Latin America, as it would help to gain a better understanding of what citizens know about RDs, as well as assess the level of exposure of
RDs through the media in each country.
The role of communication media in the process of inclusion
or stigmatization is obvious. We know from various studies on
gender, race and disabilities that the media is capable of facilitating these processes. An analysis of the media suggests that despite the availability of online information on RDs, they remain
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vastly unknown to the public at large. In a similar manner, despite progress in recent years, RDs remain an unfamiliar topic for
journalists and society as a whole (Bañón & Requena, 2014).
As a result, information professionals face multiple barriers, such as ignorance, unknown terminology, technological
difficulties, and health and social complexities (Vicente, 2011, p.
395). These barriers could lead to information errors or avoidance, given that these themes may be considered too complex
for their audiences. On the other hand, the perception of RD
patient associations and patient families is that not enough
progress has been made related to media visibility. Although
media exposure has increased, it seems to be mostly limited to
the International Day of RD. As Bañón and Fornieles say, “As
these actions only take place at a particular moment, they only
leave a temporary footprint that fails to give a clear picture of
the existence and nature of those diseases amongst the public”
(2011, p. 12).
From this, it becomes clear that we must carefully examine
the accuracy, ethics and adequacy of the RD content disseminated by media such as newspapers, radio, TV and Internet. At
the same time, it is necessary to influence the priorities of journalists to make sure RDs receive the coverage they deserve. It
is also important to generate guidelines to help us interact with
the media. Bañón and Fornieles (2011, pp. 203-206) propose that:
•

The growing interest in RDs shown by the Spanish
media must be consolidated.

•

We must enter a new phase of communication
about RDs in that the quality of information
must improve.

•

Authoritative sources, including researchers and
RD patient associations, must be properly used.

•

There is a need to better integrate RDs into the
affairs of communication media.

•

Communication professionals need additional
training in the area of RDs.
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•

We should not use sensationalism to portray
patients with RDs nor describe them as people
in need of compassion. They should not be
perceived as strange people.

•

The media should investigate what health
authorities say and what they actually do in
relation to RDs.

•

The attention given to leaders that support RDs
should not overshadow the defense of the rights
of patients and their families, and working towards
better diagnosis, medical research or therapies.

•

Media professionals must remember that they are
also agents for reporting incorrect actions in health,
social or educational fields.

•

Media representation of conflicts or collaboration
between professionals or public administration
and patients should be used to reflect upon
good and bad practice.

Recommendations for
Improving Patient Wellbeing
The following priorities have been adopted by ALIBER in
Latin America
•

Promote the inclusion of RDs in public health plans

•

Promote RD research

•

Disseminate RD-related information to patients,
health workers and the general public

•

Train health and social workers in RDs

•

Recognize the unique social and health rights of
RD patients
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•

Promote the creation of referral centers to improve
access to and quality of care for RD patients

•

Facilitate access to needed resources for a rapid
diagnosis

•

Encourage the development of and access to drugs
and therapies for RDs

•

Support the RD association movement

•

Establish national and international collaborations
related to RDs (ALIBER, 2016)

Consistent with the recommendations of Fernández, Lozano, and Riano (2015), we propose considering four proposals in
the political arena:
•

Survey Spanish public opinion on a regular basis and
assess the needs of people with RDs in order to
formulate social policies that respond to those needs.

•

Secure the support of national, regional and local
governments in the development of comprehensive
plans related to their areas of competence.

•

Provide training, increase sensitization, and
coordinate specialized health and social services
that respond to the diverse needs of people with RDs.

•

Work towards the necessary coordination and
reciprocal support that should exist between the
different government agencies and representatives
of civil society.

Conclusion
It is clear that without scientific research, there is no future or hope for the over 7,000 rare diseases currently known.
The real challenge for research in rare diseases is to advance
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the discovery of treatments and detection of new diseases. It
is true that progress has been made (Ministerio de Sanidad y
Consumo, 2003, 2006; Ministerio de Sanidad y de Política Social,
2009). However, it is also necessary to make progress in communication and in social and educational issues. It is estimated
that between 6 and 8% of the world population may be affected
by one of these diseases; that is more than 42 million people
in Latin America and more than 350 million people worldwide
(ALIBER, 2016).
To approach these problems, we need global exposure and
coordinated efforts and resources at the local, regional and national levels. These efforts must involve government authorities, professionals, the pharmaceutical industry, the mass media, patient organizations and society in general (Organización
Mundial de la Salud [World Health Organization], 2012). Likewise, a multi-faceted strategy is required to respond to the most
urgent health problems through prevention, planning, and primary care (Garcia-Ribes, 2006). Social workers are key players
in the association movement in Latin America. The increase in
the number of associations and foundations in Latin America
in recent years has resulted in the need to meet and share experiences, consolidating the Latin American Alliance of Rare
Diseases (ALIBER) as a worldwide model.
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